Multicenter comparison of automated procalcitonin immunoassays
- PMID: 28932801
- PMCID: PMC5597721
- DOI: 10.1016/j.plabm.2015.07.001
Multicenter comparison of automated procalcitonin immunoassays
Abstract
Objectives: A multicenter study to compare results of BRAHMS Kryptor PCT with those obtained using four BRAHMS-partnered procalcitonin (PCT) automated immunoassays (DiaSorin Liaison, BioMérieux Vidas, Roche Cobas E601 and Siemens Advia Centaur) and the Diazyme immunotubidimetric assay implemented on four clinical chemistry platforms (Abbott Architect c16000, Siemens Advia 2400, Roche Cobas C501 and Beckman Coulter AU5800).
Design and methods: One hundred serum samples from in-patients with PCT values between 0.10 and 58.7 ng/mL were divided into aliquots and tested with the nine different reagents and analyzers. BRAHMS PCT Kryptor results were used as reference.
Results: Compared to BRAHMS PCT Kryptor, significant differences in results were observed on Vidas, Advia Centaur, Architect, Cobas C501 and AU5800. However, the correlation coeffiecients (r) with BRAHMS PCT Kryptor were between 0.899 and 0.988. The mean bias was less than ±1.02 ng/mL, except for Vidas (2.70 ng/mL). The agreement at three clinically relevant cut-offs was optimal: between 83-98% at 0.50 ng/mL, 90-97% at 2.0 ng/mL, and 98% at 10 ng/mL. The comparison of Diazyme PCT across the four clinical chemistry analyzers yielded high correlation coefficients (r between 0.952 and 0.976), a mean bias less than ±0.9 ng/mL, acceptable agreement at 0.5 ng/mL (>82%), and high concordance at the 2.0 ng/mL (>97%) and 10 ng/mL (>98%) cut-offs.
Conclusions: The methods and applications evaluated in this multicenter study are aligned with BRAHMS PCT Kryptor and can be used for predicting the risk of progression to systemic inflammation in patients with bacterial infections using the conventional PCT diagnostic thresholds.
Keywords: Bacterial infections; Immunoassay; Multicenter study; Procalcitonin; Sepsis.
Figures


Similar articles
-
Two-center comparison of 10 fully-automated commercial procalcitonin (PCT) immunoassays.Clin Chem Lab Med. 2019 Dec 18;58(1):77-84. doi: 10.1515/cclm-2019-0888. Clin Chem Lab Med. 2019. PMID: 31539351
-
Comparison of Procalcitonin Assays on KRYPTOR and LIAISON® XL Analyzers.Diagnostics (Basel). 2019 Aug 8;9(3):94. doi: 10.3390/diagnostics9030094. Diagnostics (Basel). 2019. PMID: 31398868 Free PMC article.
-
Comparison of a novel automated DiaSys procalcitonin immunoassay with four different BRAHMS-partnered immunoassays.Pract Lab Med. 2022 Apr 12;30:e00274. doi: 10.1016/j.plabm.2022.e00274. eCollection 2022 May. Pract Lab Med. 2022. PMID: 35465623 Free PMC article.
-
Evaluation of procalcitonin immunoassay concordance near clinical decision points.Clin Chem Lab Med. 2019 Aug 27;57(9):1414-1421. doi: 10.1515/cclm-2018-1362. Clin Chem Lab Med. 2019. PMID: 30763263
-
A new sensitive automated assay for procalcitonin detection: LIAISON® BRAHMS PCT® II GEN.Pract Lab Med. 2016 Jun 27;6:1-7. doi: 10.1016/j.plabm.2016.06.002. eCollection 2016 Dec 1. Pract Lab Med. 2016. PMID: 28856207 Free PMC article.
Cited by
-
Procalcitonin measurement to screen medullary thyroid carcinoma: A prospective evaluation in a series of 2705 patients with thyroid nodules.Eur J Clin Invest. 2018 Jun;48(6):e12934. doi: 10.1111/eci.12934. Epub 2018 Apr 20. Eur J Clin Invest. 2018. PMID: 29635700 Free PMC article.
-
Agreement Between Two Procalcitonin Assays in Hospitalized Children.Infect Dis Ther. 2019 Sep;8(3):463-468. doi: 10.1007/s40121-019-0250-5. Epub 2019 Jun 29. Infect Dis Ther. 2019. PMID: 31256335 Free PMC article.
-
Procalcitonin detection in human plasma specimens using a fast version of proximity extension assay.PLoS One. 2023 Feb 16;18(2):e0281157. doi: 10.1371/journal.pone.0281157. eCollection 2023. PLoS One. 2023. PMID: 36795693 Free PMC article.
-
Analytical Evaluation of Point-of-Care Finecare™ Procalcitonin Rapid Quantitative Test in Sepsis Population as Compared with Elecsys® BRAHMS Procalcitonin Immunoassay.Diagnostics (Basel). 2024 May 22;14(11):1080. doi: 10.3390/diagnostics14111080. Diagnostics (Basel). 2024. PMID: 38893607 Free PMC article.
-
Candidate High-Resolution Mass Spectrometry-Based Reference Method for the Quantification of Procalcitonin in Human Serum Using a Characterized Recombinant Protein as a Primary Calibrator.Anal Chem. 2022 Mar 15;94(10):4146-4154. doi: 10.1021/acs.analchem.1c03061. Epub 2022 Mar 2. Anal Chem. 2022. PMID: 35235744 Free PMC article.
References
-
- Meisner M. 1st ed. UNI-MED; Bremen: 2010. Procalcitonin-Biochemistry and Clinical Diagnosis. ISBN 978-3-8374-1241-3.
-
- Lippi G., Danese E., Cervellin G., Montagnana M. Laboratory diagnostics of spontaneous bacterial peritonitis. Clin. Chim. Acta. 2014;430:164–170. - PubMed
-
- Lippi G., Meschi T., Cervellin G. Inflammatory biomarkers for the diagnosis, monitoring and follow-up of community-acquired pneumonia: clinical evidence and perspectives. Eur. J. Intern. Med. 2011;22:460–465. - PubMed
-
- Soni N.J., Samson D.J., Galaydick J.L., Vats V., Pitrak D.L., Aronson N. Agency for Healthcare Research and Quality (US); Rockville (MD): 2012. Procalcitonin-Guided Antibiotic Therapy. October. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources